| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0424 |
| Trial ID | NCT03467256 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Tocilizumab|Cytarabine|Etoposide|Dexamethasone |
| Generation | 2nd |
| Phase | Phase1|Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL |
| Year | 2018 |
| Country | Russian Federation |
| Company sponsor | Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
| Other ID(s) | NCPHOI-2018-01 |
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||